Table 1 |
|
|
Patient and tumor characteristics. |
|
|
Patient and tumor characteristics |
No. of patients |
|
|
|
|
FIGO stage |
|
|
Early (I-IIA) |
20 |
|
Advanced (IIB-IV) |
45 |
|
Unknown |
10 |
|
Histological type |
|
|
Serous adenocarcinoma |
36 |
|
Endometrioid adenocarcinoma |
13 |
|
Mucinous adenocarcinoma |
10 |
|
Clear cell adenocarcinoma |
3 |
|
Mixed Mullerian Tumor |
8 |
|
Poorly differentiated |
3 |
|
Unknown |
2 |
|
Tumor grade |
|
|
1 |
12 |
|
2 |
29 |
|
3 |
27 |
|
Unknown |
7 |
|
Residual disease |
|
|
None |
25 |
|
≤ 1 cm |
15 |
|
> 1 cm |
22 |
|
Unknown |
13 |
|
Chemotherapy |
|
|
Cisplatin & endoxan |
45 * |
|
Carboplatin & endoxan |
1 * |
|
Other, not platinum containing |
5 |
|
No chemotherapy |
11 |
|
Unknown |
12 |
|
* Response to platinum-based chemotherapy |
|
|
No response |
11 |
|
Response |
34 |
|
Unknown |
1 |
|
|
|
|
Total |
75 |
|
|
|
|
Helleman et al. BMC Cancer 2006 6:201 doi:10.1186/1471-2407-6-201 |
|
